TABLE 2.

Patient Demographics and Disease Characteristics of Treated Patients

	Academic Centers	Community Centers
	(n = 1905)	(n = 1165)
Male	1125 (59)	708 (61)
Age [mean (SD)] (y)	47.6 (8.1)	47.4 (7.8)
> 40	1623 (85)	990 (85)
Weight [mean (SD)] (kg)	83.4 (16.3)	83.5 (16.3)
Race
White	1348 (71)	841 (72)
Black	400 (21)	170 (15)
Hispanic	96 (5)	117 (10)
Asian	28 (1)	23 (2)
Baseline HCV-RNA
> 600,000 IU/mL	1561 (82)	957 (82)
Genotype 1 subtype
1a	1172 (62)	747 (64)
1b	695 (36)	390 (33)
1a1b	34 (2)	24 (2)
ALT
Abnormal (>ULN)	645 (73)	944 (81)
Steatosis*
Absent	694 (36)	423 (36)
Present	1107 (58)	699 (60)
Metavir fibrosis score*
F0/1/2	1603 (84)	992 (85)
F3/4	198 (10)	130 (11)

^*Data missing for 147 patients (104 in academic-based and 43 in community-based centers).

ALT indicates alanine aminotransferase; HCV, hepatitis C virus; ULN, upper limit of normal.